Can sofosbuvir and velpatasvir cure hepatitis C? What is the success rate?

吉三代(sofosbuvir and velpatasvir)obtained for the first timeFDA in June 2016 pan>Approved, It is approved for use in patients with chronic Hepatitis C virus (HCV)genotype1, 2, 3, 4, span>5 or 6 infected adults and children at least 3 years old. G3 is used together with ribavirin for patients with advanced liver disease (decompensated cirrhosis). In 20178month, FDA also approved Jisanda for the treatment of chronic HCV in patients co-infected with HIV.

Gen III (sofosbuvir and velpatasvir) can cure hepatitis C virus (HCV) in many patients and has an overall cure rate of 98% across all 6 major types of hepatitis C. "Cure" means no hepatitis C virus is detected in the blood when measured three months after completion of treatment. In the study, these cure rates were seen in genotypes 1-6without cirrhosis (a serious liver disease) or compensated cirrhosis (means you have cirrhosis but mild or no symptoms).

With SVR, viruses are no longer detected, from 80% to 100%of patients can be cured, sometimes with only 8 to 12 weeks of treatment. However, resistance can develop, so two or more oralHCV drugs will be used together to help prevent resistance. It is important to seek treatment for hepatitis C early to increase the chances of cure and help prevent severe liver damage and possible death.

There are generic drugs overseas. The officially marketed version has the same ingredients and dosage specifications as the original drug. A course of treatment costs about 3000 or so. If you want to get more high-quality information, you can contact Yaode, and Yaode will do its best to learn more about high-quality overseas drugs for you.

xa0